Adoptive transfer of DXM/lactoferrin PMN-MDSCs, Con PMN-MDSCs, or tumor PMN-MDSCs were conducted i.v. before and after cisplatin treatment, with PBS and DXM treatments serving as controls (Fig. 5a). This evidence concerns the gene LTF and neoplasm.